Literature DB >> 9297241

[Preparation and technique for surgical treatment of 225 acetabulum fractures. 2 year results of 175 cases].

P M Rommens1, P L Broos, P Vanderschot.   

Abstract

Between December 1986 and November 1995, 222 patients with 225 acetabular fractures were treated operatively by three surgeons in the Department of Traumatology and Emergency Surgery of the University Hospitals of the Catholic University of Leuven. Indications for surgery were unstable fracture, displaced fracture through the acetabular dome and fracture with intra-acetabular fracture fragments. There were 37.3% A-fractures, 49.7% B-fractures, and 13% C fractures according to the AO Classification. In 16.4% of fractures there were primary neurological deficits. Patients were treated operatively after an average of 5.0 days. The Kocher-Langenbeck approach was used in 56.9% of cases, the ilio-inguinal approach in 27.1% and the extended iliofemoral approach in 4%. In 7.1% of patients, a primary total hip endoprosthesis was implanted. There was no intra- oder perioperative mortality. The average hospital stay was 26.1 days. In 7.1% of patients, we noted secondary neurological problems. Deep infections were present in 1.3%. In 11.1% of patients a second operative procedure was necessary. We were able to review 175 patients after an average of 2 years. Signs of arthrosis and periarticular ossification were noted on the x-rays: walking distance, hip mobility and pain intensity were asked about and recorded after the clinical examination. In 76% of patients an excellent or good result on the Merle-d'Aubigne scale was obtained. T-fractures and posterior wall fractures were followed by the worst results. During this 9-year period, changes have been made to the preoperative radiological examination carried out, the choice of operative approach and our policy on prevention of thrombosis prophylaxis and postoperative ossification. After thorough preoperative diagnosis and with a meticulous operative technique, it is possible to stabilise the vast majority of acetabular fractures through the three classical approaches. Because the fractures are relatively rare, their diagnosis complex and their surgical treatment difficult, specific training is essential for every acetabular surgeon.

Entities:  

Mesh:

Year:  1997        PMID: 9297241     DOI: 10.1007/s001130050128

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  7 in total

Review 1.  [Acetabular fractures].

Authors:  A Gänsslen; H J Oestern
Journal:  Chirurg       Date:  2011-12       Impact factor: 0.955

2.  [Auxiliary cerclage-wiring in internal fixation of displaced acetabular fractures].

Authors:  C J Erichsen; C von Rüden; C Hierholzer; V Bühren; A Woltmann
Journal:  Unfallchirurg       Date:  2015-01       Impact factor: 1.000

3.  [Complex regional pain syndrome. A rare complication after acetabular fracture].

Authors:  A Lingawi; M H Hessmann; F Birklein; A Hofmann; P Ingelfinger; P M Rommens
Journal:  Unfallchirurg       Date:  2008-03       Impact factor: 1.000

4.  Results of operative treatment of acetabular fractures from the Third World--how local factors affect the outcome.

Authors:  Ravi K Gupta; Harmeet Singh; Bias Dev; Rajeev Kansay; Parmanand Gupta; Sudhir Garg
Journal:  Int Orthop       Date:  2007-10-17       Impact factor: 3.075

5.  Modified ilioinguinal approach in combined surgical exposures for displaced acetabular fractures involving two columns.

Authors:  Peng Wang; Xiaodong Zhu; Peng Xu; Yan Zhang; Lubo Wang; Xiangyan Liu; Weidong Mu
Journal:  Springerplus       Date:  2016-09-19

6.  Outcome of surgical treatment for displaced acetabular fractures: a prospective study.

Authors:  Sahu Ramji Lal
Journal:  Rev Bras Ortop       Date:  2017-12-29

7.  Open reduction and internal fixation of acetabular fractures in patients of old age.

Authors:  Pol Maria Rommens; Roland Schwab; Kristin Handrich; Charlotte Arand; Daniel Wagner; Alexander Hofmann
Journal:  Int Orthop       Date:  2020-07-30       Impact factor: 3.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.